Embecta Corp. (EMBC)
6.21
-0.06
(-0.96%)
USD |
NASDAQ |
Oct 19, 16:00
6.22
+0.01
(+0.16%)
After-Hours: 20:00
Embecta Gross Profit Margin (Quarterly) : 55.47% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 55.47% |
| March 31, 2026 | 56.45% |
| December 31, 2025 | 67.23% |
| September 30, 2025 | 59.09% |
| June 30, 2025 | 65.99% |
| March 31, 2025 | 62.36% |
| December 31, 2024 | 63.73% |
| September 30, 2024 | 59.87% |
| June 30, 2024 | 68.95% |
| March 31, 2024 | 64.14% |
| December 31, 2023 | 67.04% |
| Date | Value |
|---|---|
| September 30, 2023 | 64.49% |
| June 30, 2023 | 66.24% |
| March 31, 2023 | 68.50% |
| December 31, 2022 | 68.48% |
| September 30, 2022 | 64.42% |
| June 30, 2022 | 69.70% |
| March 31, 2022 | 69.65% |
| December 31, 2021 | 70.48% |
| September 30, 2021 | 69.82% |
| June 30, 2021 | 68.68% |
| March 31, 2021 | 69.07% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Artivion, Inc. | 60.67% |
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 7.77% |
| Return on Invested Capital | 10.73% |
| Profit Margin (Quarterly) | 7.77% |
| Operating Margin (Quarterly) | 23.67% |
| Return on Net Operating Assets | 12.95% |